نبذة مختصرة : Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness medically unexplained, affecting approximately 1% of the global population. Due to the subjective complaint, assessing the exact severity of fatigue is a clinical challenge, thus, this study aimed to produce comprehensive features of fatigue severity in ME/CFS patients.
Methods: We systematically extracted the data for fatigue levels of participants in randomized controlled trials (RCTs) targeting ME/CFS from PubMed, Cochrane Library, Web of Science, and CINAHL throughout January 31, 2024. We normalized each different measurement to a maximum 100-point scale and performed a meta-analysis to assess fatigue severity by subgroups of age, fatigue domain, intervention, case definition, and assessment tool, respectively.
Results: Among the total of 497 relevant studies, 60 RCTs finally met our eligibility criteria, which included a total of 7088 ME/CFS patients (males 1815, females 4532, and no information 741). The fatigue severity of the whole 7,088 patients was 77.9 (95% CI 74.7-81.0), showing 77.7 (95% CI 74.3-81.0) from 54 RCTs in 6,706 adults and 79.6 (95% CI 69.8-89.3) from 6 RCTs in 382 adolescents. Regarding the domain of fatigue, 'cognitive' (74.2, 95% CI 65.4-83.0) and 'physical' fatigue (74.3, 95% CI 68.3-80.3) were a little higher than 'mental' fatigue (70.1, 95% CI 64.4-75.8). The ME/CFS participants for non-pharmacological intervention (79.1, 95% CI 75.2-83.0) showed a higher fatigue level than those for pharmacological intervention (75.5, 95% CI 70.0-81.0). The fatigue levels of ME/CFS patients varied according to diagnostic criteria and assessment tools adapted in RCTs, likely from 54.2 by ICC (International Consensus Criteria) to 83.6 by Canadian criteria and 54.2 by MFS (Mental Fatigue Scale) to 88.6 by CIS (Checklist Individual Strength), respectively.
Conclusions: This systematic review firstly produced comprehensive features of fatigue severity in patients with ME/CFS. Our data will provide insights for clinicians in diagnosis, therapeutic assessment, and patient management, as well as for researchers in fatigue-related investigations.
(© 2024. The Author(s).)
References: Jason LA, et al. Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis. Fatigue Biomed Health Behav. 2014;2(1):40–56. (PMID: 10.1080/21641846.2013.862993)
Wallin MT, et al. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(3):269–85. (PMID: 10.1016/S1474-4422(18)30443-5)
Pendergrast T, et al. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016;12(4):292–307. (PMID: 27127189546436210.1177/1742395316644770)
Roberts E, et al. Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) register. The Lancet. 2016;387(10028):1638–43. (PMID: 10.1016/S0140-6736(15)01223-4)
Yoon J-H, et al. The demographic features of fatigue in the general population worldwide: a systematic review and meta-analysis. Front Public Health. 2023;11:1192121. (PMID: 375751031041679710.3389/fpubh.2023.1192121)
Kang Y-E, et al. Prevalence of cancer-related fatigue based on severity: a systematic review and meta-analysis. Sci Rep. 2023;13(1):12815. (PMID: 375503261040692710.1038/s41598-023-39046-0)
Lukkahatai N, Saligan LN. Association of catastrophizing and fatigue: a systematic review. J Psychosom Res. 2013;74(2):100–9. (PMID: 2333252310.1016/j.jpsychores.2012.11.006)
Ghanean H, Ceniti AK, Kennedy SH. Fatigue in patients with major depressive disorder: prevalence, burden and pharmacological approaches to management. CNS Drugs. 2018;32:65–74. (PMID: 2938357310.1007/s40263-018-0490-z)
Falk Hvidberg M, et al. The health-related quality of life for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). PLoS ONE. 2015;10(7): e0132421. (PMID: 26147503449297510.1371/journal.pone.0132421)
Goërtz YM, et al. Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Sci Rep. 2021;11(1):20977. (PMID: 34697347854608610.1038/s41598-021-00337-z)
Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–70. (PMID: 1501657310.1016/S0022-3999(03)00371-4)
Vercoulen JH, et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–92. (PMID: 796592710.1016/0022-3999(94)90099-X)
Chalder T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–53. (PMID: 846399110.1016/0022-3999(93)90081-P)
Fisk JD, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Supplement_1):79–83. (PMID: 10.1093/clinids/18.Supplement_1.S79)
Jason LA, et al. Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disability studies quarterly: DSQ. 2011; 31(1).
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9. (PMID: 1962251110.7326/0003-4819-151-4-200908180-00135)
Sterne JA, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. (PMID: 3146253110.1136/bmj.l4898)
Borenstein M, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111. (PMID: 2606137610.1002/jrsm.12)
Egger M, Smith GD. Meta-analysis bias in location and selection of studies. BMJ. 1998;316(7124):61–6. (PMID: 9451274266533410.1136/bmj.316.7124.61)
Groenvold M, et al. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105:209–19. (PMID: 1720338610.1007/s10549-006-9447-x)
van’t Leven M, et al. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health. 2010;20(3):251–7. (PMID: 10.1093/eurpub/ckp113)
Smets E, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25. (PMID: 763677510.1016/0022-3999(94)00125-O)
Chu L, et al. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2019;7:12. (PMID: 30805319637074110.3389/fped.2019.00012)
Castro-Marrero J, et al. Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain. BMC Public Health. 2019;19(1):1–13. (PMID: 10.1186/s12889-019-7225-z)
Lidbury BA, Fisher PR. Biomedical Insights that Inform the Diagnosis of ME/CFS. 2020, MDPI. p. 92.
Vink M, Vink-Niese F. Work rehabilitation and medical retirement for myalgic encephalomyelitis/chronic fatigue syndrome patients. A review and appraisal of diagnostic strategies. Diagnostics. 2019;9(4):124. (PMID: 31547009696383110.3390/diagnostics9040124)
Huether AX, Pottinger T, Lou J-S. Screening cut-off scores for clinically significant fatigue in early Parkinson’s disease. Clin Parkinsonism Relat Disord. 2023;9: 100228. (PMID: 10.1016/j.prdoa.2023.100228)
Wintermann G-B, et al. Fatigue in chronically critically ill patients following intensive care-reliability and validity of the multidimensional fatigue inventory (MFI-20). Health Qual Life Outcomes. 2018;16(1):1–10. (PMID: 10.1186/s12955-018-0862-6)
Ericsson A, et al. Resistance exercise improves physical fatigue in women with fibromyalgia: a randomized controlled trial. Arthritis Res Ther. 2016;18:1–12. (PMID: 10.1186/s13075-016-1073-3)
Werumeus Buning J, et al. Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial. Neuroendocrinology. 2016;103(6):771–8. (PMID: 2664675110.1159/000442985)
Ramírez-Morales R, et al. Clinical overlap between fibromyalgia and myalgic encephalomyelitis. A systematic review and meta-analysis. Autoimmun Rev. 2022;21(8):103129. (PMID: 3569024710.1016/j.autrev.2022.103129)
Baldwin DS, Papakostas GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006;67:9. (PMID: 16848671)
Simon GE, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341(18):1329–35. (PMID: 1053612410.1056/NEJM199910283411801)
Van Langenberg D, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(2):131–43. (PMID: 2045630910.1111/j.1365-2036.2010.04347.x)
Sandler CX, Lloyd AR. Chronic fatigue syndrome: progress and possibilities. Med J Aust. 2020;212(9):428–33. (PMID: 3224853610.5694/mja2.50553)
Unger ER, et al. CDC grand rounds: chronic fatigue syndrome—advancing research and clinical education. Morb Mortal Wkly Rep. 2016;65(50 & 51):1434–8. (PMID: 10.15585/mmwr.mm655051a4)
Menzies V, et al. A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases. Chronic Illn. 2021;17(2):129–50. (PMID: 3088496510.1177/1742395319836472)
Bonner A, Wellard S, Caltabiano M. The impact of fatigue on daily activity in people with chronic kidney disease. J Clin Nurs. 2010;19(21–22):3006–15. (PMID: 2104000710.1111/j.1365-2702.2010.03381.x)
Zhang Y-Y, et al. Determinants of compassion satisfaction, compassion fatigue and burn out in nursing: a correlative meta-analysis. Medicine. 2018;97(26): e11086. (PMID: 29952947624230910.1097/MD.0000000000011086)
Engberg I, et al. Fatigue in the general population-associations to age, sex, socioeconomic status, physical activity, sitting time and self-rated health: the northern Sweden MONICA study 2014. BMC Public Health. 2017;17(1):1–9. (PMID: 10.1186/s12889-017-4623-y)
Dinos S, et al. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol. 2009;38(6):1554–70. (PMID: 1934947910.1093/ije/dyp147)
Loge JH, Ekeberg Ø, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45(1):53–65. (PMID: 972085510.1016/S0022-3999(97)00291-2)
Lewis I, et al. Is chronic fatigue syndrome in older patients a different disease? A clinical cohort study. Eur J Clin Invest. 2013;43(3):302–8. (PMID: 2339795510.1111/eci.12046)
Al-Haggar MS, Al-Naggar ZA, Abdel-Salam MA. Biofeedback and cognitive behavioral therapy for Egyptian adolescents suffering from chronic fatigue syndrome. J Pediatr Neurol. 2006;4(03):161–9. (PMID: 10.1055/s-0035-1557320)
Lim E-J, et al. Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea. J Transl Med. 2021;19:1–6. (PMID: 10.1186/s12967-021-03170-0)
Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 1997;314(7095):1647. (PMID: 9180065212686810.1136/bmj.314.7095.1647)
Kim D-Y, et al. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18(1):1–12.
Shepherd CB. PACE trial claims for recovery in myalgic encephalomyelitis/chronic fatigue syndrome–true or false? It’s time for an independent review of the methodology and results. J Health Psychol. 2017;22(9):1187–91. (PMID: 2880552210.1177/1359105317703786)
Health, N.I.f. and C. Excellence, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. 2021: National Institute for Health and Care Excellence (NICE).
Lim E-J, Son C-G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2020;18(1):1–10. (PMID: 10.1186/s12967-020-02455-0)
Jason LA, et al. Comparing the Fukuda et al. criteria and the Canadian case definition for chronic fatigue syndrome. J Chronic Fatigue Syndr. 2004;12(1):37–52. (PMID: 10.1300/J092v12n01_03)
Beurskens AJ, et al. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med. 2000;57(5):353–7. (PMID: 10769302173995010.1136/oem.57.5.353)
Sharpe M, et al. Chronic fatigue syndrome: a practical guide to assessment and management. Gen Hosp Psychiatry. 1997;19(3):185–99. (PMID: 921898710.1016/S0163-8343(97)80315-5)
Processing Request
No Comments.